- Report
- August 2022
- 140 Pages
Global
From €2798EUR$3,188USD£2,448GBP
€3731EUR$4,250USD£3,264GBP
- Report
- January 2025
- 196 Pages
Global
From €4385EUR$4,995USD£3,836GBP
- Report
- June 2024
- 211 Pages
Global
From €4385EUR$4,995USD£3,836GBP
- Report
- June 2024
- 200 Pages
Global
From €4385EUR$4,995USD£3,836GBP
- Report
- May 2024
- 250 Pages
Global
From €4385EUR$4,995USD£3,836GBP
- Report
- May 2024
- 250 Pages
Global
From €4385EUR$4,995USD£3,836GBP
- Report
- March 2024
- 81 Pages
Global
€4385EUR$4,995USD£3,836GBP
- Report
- March 2024
- 185 Pages
Asia Pacific
€4385EUR$4,995USD£3,836GBP
- Report
- January 2024
- 258 Pages
Global
€4385EUR$4,995USD£3,836GBP
- Report
- January 2024
- 120 Pages
Global
€4385EUR$4,995USD£3,836GBP
- Report
- February 2026
- 150 Pages
Canada
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
China
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
Germany
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
India
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 193 Pages
Canada
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 202 Pages
China
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 195 Pages
India
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- December 2025
- 150 Pages
Germany
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- November 2025
- 150 Pages
India
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- November 2025
- 150 Pages
Japan
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more